Teva Recalling ‘Superpotent’ Drug for Parkinson’s Disease

Drug Industry Daily
A A
Teva Pharmaceutical is pulling 3,881 bottles of a generic combination drug to treat Parkinson’s disease because the tablets are potentially “superpotent,” marking another recall for the company this year.

To View This Article:

Login

Subscribe To Drug Industry Daily